Institutional investors purchased a net $2.4 million shares of DEPO during the quarter ended September 2016 and now own 102.13% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 100.0 Thousand shares of Depomed Inc
ACUITY CAPITAL MANAGEMENT LLC Bought 6.5 Thousand shares of Depomed Inc
CUTLER GROUP LP Bought 4.5 Thousand shares of Depomed Inc